JP2004502421A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2004502421A5 JP2004502421A5 JP2002507891A JP2002507891A JP2004502421A5 JP 2004502421 A5 JP2004502421 A5 JP 2004502421A5 JP 2002507891 A JP2002507891 A JP 2002507891A JP 2002507891 A JP2002507891 A JP 2002507891A JP 2004502421 A5 JP2004502421 A5 JP 2004502421A5
- Authority
- JP
- Japan
- Prior art keywords
- ser
- amino acid
- acid sequence
- gly
- asp
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 125000003275 alpha amino acid group Chemical group 0.000 claims description 18
- 102100021943 C-C motif chemokine 2 Human genes 0.000 claims description 12
- 101710155857 C-C motif chemokine 2 Proteins 0.000 claims description 12
- 239000000427 antigen Substances 0.000 claims description 4
- 102000036639 antigens Human genes 0.000 claims description 4
- 108091007433 antigens Proteins 0.000 claims description 4
- 102000006496 Immunoglobulin Heavy Chains Human genes 0.000 claims 2
- 108010019476 Immunoglobulin Heavy Chains Proteins 0.000 claims 2
- 108091007491 NSP3 Papain-like protease domains Proteins 0.000 claims 2
- 102000013463 Immunoglobulin Light Chains Human genes 0.000 claims 1
- 108010065825 Immunoglobulin Light Chains Proteins 0.000 claims 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 4
- 101100504320 Caenorhabditis elegans mcp-1 gene Proteins 0.000 description 2
- 239000004480 active ingredient Substances 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 239000013604 expression vector Substances 0.000 description 2
- FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 210000003527 eukaryotic cell Anatomy 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 239000008194 pharmaceutical composition Substances 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- 210000001236 prokaryotic cell Anatomy 0.000 description 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0016138.0A GB0016138D0 (en) | 2000-06-30 | 2000-06-30 | Organic compounds |
| PCT/EP2001/007468 WO2002002640A2 (en) | 2000-06-30 | 2001-06-29 | Antibodies to human mcp-1 |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2006314441A Division JP2007054079A (ja) | 2000-06-30 | 2006-11-21 | ヒトｍｃｐ−１に対する抗体 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2004502421A JP2004502421A (ja) | 2004-01-29 |
| JP2004502421A5 true JP2004502421A5 (https=) | 2007-03-01 |
| JP3920215B2 JP3920215B2 (ja) | 2007-05-30 |
Family
ID=9894801
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2002507891A Expired - Fee Related JP3920215B2 (ja) | 2000-06-30 | 2001-06-29 | ヒトｍｃｐ−１に対する抗体 |
| JP2006314441A Pending JP2007054079A (ja) | 2000-06-30 | 2006-11-21 | ヒトｍｃｐ−１に対する抗体 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2006314441A Pending JP2007054079A (ja) | 2000-06-30 | 2006-11-21 | ヒトｍｃｐ−１に対する抗体 |
Country Status (27)
| Country | Link |
|---|---|
| US (1) | US20040047860A1 (https=) |
| EP (1) | EP1299421B1 (https=) |
| JP (2) | JP3920215B2 (https=) |
| KR (1) | KR100603899B1 (https=) |
| CN (1) | CN100486996C (https=) |
| AR (1) | AR046379A1 (https=) |
| AT (1) | ATE426616T1 (https=) |
| AU (2) | AU8390301A (https=) |
| BR (1) | BR0112086A (https=) |
| CA (1) | CA2412775A1 (https=) |
| CZ (1) | CZ20024256A3 (https=) |
| DE (1) | DE60138102D1 (https=) |
| EC (1) | ECSP024402A (https=) |
| ES (1) | ES2322643T3 (https=) |
| GB (1) | GB0016138D0 (https=) |
| HU (1) | HUP0301477A3 (https=) |
| IL (1) | IL153721A0 (https=) |
| MX (1) | MXPA03000201A (https=) |
| NO (1) | NO20026063L (https=) |
| NZ (1) | NZ523195A (https=) |
| PE (1) | PE20020125A1 (https=) |
| PL (1) | PL207133B1 (https=) |
| PT (1) | PT1299421E (https=) |
| RU (1) | RU2314316C2 (https=) |
| SK (1) | SK18122002A3 (https=) |
| WO (1) | WO2002002640A2 (https=) |
| ZA (1) | ZA200300199B (https=) |
Families Citing this family (34)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE414151T1 (de) | 2000-03-03 | 2008-11-15 | Cambridge Antibody Tech | Antikörper gegen eotaxin und deren verwendung |
| US6946546B2 (en) | 2000-03-06 | 2005-09-20 | Cambridge Antibody Technology Limited | Human antibodies against eotaxin |
| AR037456A1 (es) | 2001-11-30 | 2004-11-10 | Biogen Inc | Anticuerpos contra proteinas quimiotacticas monocitarias |
| NZ542784A (en) * | 2002-08-19 | 2008-07-31 | Astrazeneca Ab | Antibodies directed to monocyte chemo-attractant protein-1 (MCP-1) and uses thereof |
| WO2004024921A1 (ja) | 2002-09-12 | 2004-03-25 | Juridical Foundation The Chemo-Sero-Therapeutic Research Institute | ヒト抗ヒトｍｃｐ−１抗体及び該抗体フラグメント |
| WO2005044200A2 (en) * | 2003-11-05 | 2005-05-19 | Centocor, Inc. | Methods and compositions for treating mcp-1 related pathologies |
| WO2005108431A1 (en) * | 2004-05-04 | 2005-11-17 | University Of Kentucky Research Foundation | Methods and compositions for the treatment of ocular neovascularization |
| GB0412400D0 (en) * | 2004-06-03 | 2004-07-07 | Univ Newcastle | Treatment of inflammatory conditions |
| PE20061444A1 (es) * | 2005-05-19 | 2007-01-15 | Centocor Inc | Anticuerpo anti-mcp-1, composiciones, metodos y usos |
| US8114964B2 (en) | 2005-05-19 | 2012-02-14 | Centocor, Inc. | Anti-MCP-1 antibodies, compositions, methods and uses |
| EP2041568A4 (en) * | 2006-06-15 | 2009-08-12 | CCR2 ANTAGONISTS FOR CHRONIC BREATHING REACTIONS IN ORGAN TRANSPLANTATIONS | |
| ES2434039T3 (es) * | 2006-07-24 | 2013-12-13 | Yeda Research And Development Co. Ltd. | Composiciones farmacéuticas que comprenden ccl2 para su uso en el tratamiento de la inflamación |
| US20080076120A1 (en) * | 2006-09-14 | 2008-03-27 | Millennium Pharmaceuticals, Inc. | Methods for the identification, evaluation and treatment of patients having CC-Chemokine receptor 2 (CCR-2) mediated disorders |
| CA2665808A1 (en) * | 2006-10-05 | 2008-05-22 | Centocor Ortho Biotech Inc. | Ccr2 antagonists for treatment of fibrosis |
| WO2008077945A2 (en) * | 2006-12-22 | 2008-07-03 | Ablynx N.V. | Anti-chemokine (ccl2, ccl3, ccl5, cxcl11, cxcl12) single-domain antibodies |
| CN101827610A (zh) * | 2007-06-29 | 2010-09-08 | 森托科尔奥索生物科技公司 | 抗mcp-1抗体、组合物、方法和用途 |
| US20090170770A1 (en) * | 2007-11-06 | 2009-07-02 | Ali Hafezi-Moghadam | Methods and compositions for treating conditions associated with angiogenesis using a vascular adhesion protein-1 (vap 1) inhibitor |
| RU2547595C2 (ru) | 2008-08-18 | 2015-04-10 | Пфайзер Инк | Антитела против ccr2 |
| EP2328930B1 (en) | 2008-08-20 | 2014-12-24 | Probiodrug AG | Antibodies directed against pyroglutamate monocyte chemoattractant protein-1 (mcp-1 n1pe) |
| WO2010151416A1 (en) * | 2009-06-25 | 2010-12-29 | Fred Hutchinson Cancer Research Center | Method of measuring adaptive immunity |
| WO2013192596A2 (en) | 2012-06-22 | 2013-12-27 | Sorrento Therapeutics Inc. | Antigen binding proteins that bind ccr2 |
| CA2958195A1 (en) * | 2014-08-15 | 2016-02-18 | PixarBio Corporation | Compositions for inhibiting inflammation in a subject with a spinal cord injury and methods of using the same |
| CN104198727A (zh) * | 2014-08-22 | 2014-12-10 | 广西南宁隆吉维特生物科技有限公司 | 人血清ccl2酶联免疫检测试剂盒及其制备和使用方法 |
| ES2764840T3 (es) | 2015-01-28 | 2020-06-04 | Univ Bordeaux | Uso de plerixafor para tratar y/o prevenir exacerbaciones agudas de la enfermedad pulmonar obstructiva crónica |
| CN105695495B (zh) * | 2015-12-07 | 2020-02-18 | 中国石油大学(华东) | 一种高活性人趋化因子的制备方法及用途 |
| WO2018106945A1 (en) | 2016-12-07 | 2018-06-14 | Progenity Inc. | Gastrointestinal tract detection methods, devices and systems |
| EP3554541B1 (en) | 2016-12-14 | 2023-06-07 | Biora Therapeutics, Inc. | Treatment of a disease of the gastrointestinal tract with a chemokine/chemokine receptor inhibitor |
| CN108048408B (zh) * | 2018-01-26 | 2020-02-07 | 扬州大学 | 牛单核细胞趋化蛋白-1杂交瘤细胞株、其分泌的单克隆抗体及应用 |
| EP3883635A1 (en) | 2018-11-19 | 2021-09-29 | Progenity, Inc. | Methods and devices for treating a disease with biotherapeutics |
| EP3957324A4 (en) | 2019-04-17 | 2023-02-08 | Hiroshima University | THERAPEUTIC FOR UROLOGICAL ONCOLOGY CHARACTERIZED BY BEING ADMINISTRATED IN COMBINATION WITH IL-6 INHIBITOR AND CCR2 INHIBITOR |
| CN115666704B (zh) | 2019-12-13 | 2025-09-26 | 比特比德科有限责任公司 | 用于将治疗剂递送至胃肠道的可摄取装置 |
| AU2020403913B2 (en) * | 2019-12-18 | 2024-10-10 | F. Hoffmann-La Roche Ag | Bispecific anti-CCL2 antibodies |
| CN112358547A (zh) * | 2020-09-30 | 2021-02-12 | 浙江大学 | 抗人cxcl-2单克隆抗体3-d3及其编码基因和应用 |
| CN119684454B (zh) * | 2024-12-25 | 2025-09-12 | 武汉爱博泰克生物科技有限公司 | 针对人mcp-1蛋白的抗体、抗体对和试剂盒及其用途 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9019552D0 (en) * | 1990-09-07 | 1990-10-24 | Unilever Plc | Specific binding agents |
| GB9115364D0 (en) * | 1991-07-16 | 1991-08-28 | Wellcome Found | Antibody |
| CA2572289A1 (en) * | 2004-06-30 | 2006-08-17 | Centocor, Inc. | Anti-mcp-1 antibodies, compositions, methods and uses |
-
2000
- 2000-06-30 GB GBGB0016138.0A patent/GB0016138D0/en not_active Ceased
-
2001
- 2001-06-28 PE PE2001000649A patent/PE20020125A1/es not_active Application Discontinuation
- 2001-06-28 AR ARP010103086A patent/AR046379A1/es not_active Application Discontinuation
- 2001-06-29 CZ CZ20024256A patent/CZ20024256A3/cs unknown
- 2001-06-29 CN CNB018120652A patent/CN100486996C/zh not_active Expired - Fee Related
- 2001-06-29 MX MXPA03000201A patent/MXPA03000201A/es active IP Right Grant
- 2001-06-29 EP EP01962800A patent/EP1299421B1/en not_active Expired - Lifetime
- 2001-06-29 ES ES01962800T patent/ES2322643T3/es not_active Expired - Lifetime
- 2001-06-29 IL IL15372101A patent/IL153721A0/xx unknown
- 2001-06-29 KR KR1020027017405A patent/KR100603899B1/ko not_active Expired - Fee Related
- 2001-06-29 US US10/312,022 patent/US20040047860A1/en not_active Abandoned
- 2001-06-29 AT AT01962800T patent/ATE426616T1/de not_active IP Right Cessation
- 2001-06-29 PL PL359854A patent/PL207133B1/pl not_active IP Right Cessation
- 2001-06-29 AU AU8390301A patent/AU8390301A/xx active Pending
- 2001-06-29 WO PCT/EP2001/007468 patent/WO2002002640A2/en not_active Ceased
- 2001-06-29 BR BR0112086-7A patent/BR0112086A/pt not_active IP Right Cessation
- 2001-06-29 AU AU2001283903A patent/AU2001283903B2/en not_active Ceased
- 2001-06-29 PT PT01962800T patent/PT1299421E/pt unknown
- 2001-06-29 CA CA002412775A patent/CA2412775A1/en not_active Abandoned
- 2001-06-29 JP JP2002507891A patent/JP3920215B2/ja not_active Expired - Fee Related
- 2001-06-29 DE DE60138102T patent/DE60138102D1/de not_active Expired - Lifetime
- 2001-06-29 HU HU0301477A patent/HUP0301477A3/hu unknown
- 2001-06-29 NZ NZ523195A patent/NZ523195A/en unknown
- 2001-06-29 RU RU2003100512/13A patent/RU2314316C2/ru not_active IP Right Cessation
- 2001-06-29 SK SK1812-2002A patent/SK18122002A3/sk unknown
-
2002
- 2002-12-17 NO NO20026063A patent/NO20026063L/no not_active Application Discontinuation
- 2002-12-24 EC EC2002004402A patent/ECSP024402A/es unknown
-
2003
- 2003-01-08 ZA ZA200300199A patent/ZA200300199B/en unknown
-
2006
- 2006-11-21 JP JP2006314441A patent/JP2007054079A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2004502421A5 (https=) | ||
| JP2024167313A5 (https=) | ||
| RU2495050C2 (ru) | Связующий элемент для рецептора gm-csf | |
| JP2007097598A5 (https=) | ||
| RU2003107564A (ru) | Антитела к человеческому il-1бета | |
| CA2420231A1 (en) | Antibodies to human il-1.beta. | |
| RU2007108067A (ru) | Антагонистические антитела к il-17 | |
| JP2022031635A5 (https=) | ||
| RU2421464C2 (ru) | Человеческие антитела к il-13 и их терапевтическое применение | |
| JP2024150445A5 (https=) | ||
| RU2003100512A (ru) | Антитела к человеческому мср-1 | |
| JP2003523764A5 (https=) | ||
| JP2020500834A5 (https=) | ||
| JP2018535650A5 (https=) | ||
| JP2003525061A5 (https=) | ||
| JP2008515446A5 (https=) | ||
| JP2010528601A5 (https=) | ||
| KR950005327A (ko) | 임파구 항원 CD2 및 종양 항원을 인식하는 이특이적 트리거(Trigger) 분자 | |
| JP2006511516A5 (https=) | ||
| CN115925919A (zh) | 改进的血清白蛋白结合免疫球蛋白可变结构域 | |
| JP2009532336A5 (https=) | ||
| JP2008508859A5 (https=) | ||
| JP2006512899A5 (https=) | ||
| JP2025183307A5 (https=) | ||
| JP2011505867A5 (https=) |